Cargando…
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients
Hypoglycemia is the most common side effects for most glucose-lowering therapies. It constitutes a serious risk that faces diabetic patients who fast during Ramadan (the 9th month in the Islamic calendar). New glucose-lowering classes like dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like pep...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013205/ https://www.ncbi.nlm.nih.gov/pubmed/27642611 http://dx.doi.org/10.1155/2016/6962574 |